Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$20.83 -2.8%	$22.17	$19.10 ▼ $29.55	$1.02B	1.79	420,336 shs	408,131 shs
INSP Inspire Medical Systems	$126.94 -0.8%	$136.24	$123.00 ▼ $225.00	$3.77B	1.25	559,407 shs	406,188 shs
SLNO Soleno Therapeutics	$87.20 -0.5%	$79.81	$41.50 ▼ $90.32	$4.42B	-2.63	853,684 shs	1.19 million shs
TMDX TransMedics Group	$109.88 -2.3%	$127.13	$55.00 ▼ $177.37	$3.81B	2.06	1.38 million shs	789,501 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	-2.75%	-5.10%	-3.21%	-4.93%	-7.46%
INSP Inspire Medical Systems	-0.99%	-2.71%	-2.31%	-15.61%	-12.77%
SLNO Soleno Therapeutics	-0.50%	+6.90%	+9.85%	+24.61%	+79.13%
TMDX TransMedics Group	-2.35%	-2.29%	-11.39%	+24.52%	-26.37%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLFS BioLife Solutions	2.3967 of 5 stars	3.5	1.0	0.0	2.5	2.5	0.6
INSP Inspire Medical Systems	4.8691 of 5 stars	4.4	2.0	4.8	2.9	2.5	1.9
SLNO Soleno Therapeutics	4.1837 of 5 stars	3.5	1.0	4.6	2.7	2.5	0.6
TMDX TransMedics Group	2.0926 of 5 stars	2.4	1.0	0.0	2.2	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	3.00	Buy	$31.17	49.62% Upside
INSP Inspire Medical Systems	2.73	Moderate Buy	$210.27	65.65% Upside
SLNO Soleno Therapeutics	3.09	Buy	$108.70	24.66% Upside
TMDX TransMedics Group	2.89	Moderate Buy	$129.88	18.20% Upside

Current Analyst Ratings Breakdown

Latest BLFS, SLNO, TMDX, and INSP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	INSP Inspire Medical Systems	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$200.00 ➝ $182.00
7/15/2025	TMDX TransMedics Group	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$129.00 ➝ $142.00
7/11/2025	SLNO Soleno Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$105.00 ➝ $121.00
6/23/2025	SLNO Soleno Therapeutics	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/23/2025	SLNO Soleno Therapeutics	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$110.00
6/17/2025	TMDX TransMedics Group	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$130.00 ➝ $150.00
6/17/2025	TMDX TransMedics Group	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
6/4/2025	TMDX TransMedics Group	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$125.00 ➝ $145.00
6/3/2025	TMDX TransMedics Group	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/13/2025	BLFS BioLife Solutions	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $30.00
5/9/2025	TMDX TransMedics Group	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$125.00 ➝ $130.00

(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$82.25M	12.11	$0.12 per share	174.84	$7.52 per share	2.77
INSP Inspire Medical Systems	$802.80M	4.66	$1.69 per share	74.90	$23.01 per share	5.52
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	$5.68 per share	N/A
TMDX TransMedics Group	$441.54M	8.42	$1.61 per share	68.39	$6.81 per share	16.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$20.18M	-$0.29	N/A	N/A	N/A	-11.81%	-0.66%	-0.58%	8/14/2025 (Estimated)
INSP Inspire Medical Systems	$53.51M	$2.17	58.50	39.42	1.96	7.92%	10.00%	8.68%	8/5/2025 (Estimated)
SLNO Soleno Therapeutics	-$175.85M	-$4.62	N/A	N/A	N/A	N/A	-77.52%	-63.44%	8/6/2025 (Estimated)
TMDX TransMedics Group	$35.46M	$1.36	80.79	76.84	N/A	10.03%	21.88%	6.15%	7/30/2025 (Estimated)

Latest BLFS, SLNO, TMDX, and INSP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	BLFS BioLife Solutions	-$0.02	N/A	N/A	N/A	N/A	N/A
8/6/2025	Q2 2025	SLNO Soleno Therapeutics	-$0.85	N/A	N/A	N/A	$3.91 million	N/A
8/5/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	N/A	N/A	N/A	$214.50 million	N/A
7/30/2025	Q2 2025	TMDX TransMedics Group	$0.48	N/A	N/A	N/A	$146.64 million	N/A
5/8/2025	Q1 2025	BLFS BioLife Solutions	-$0.03	$0.04	+$0.07	-$0.01	$22.22 million	$23.94 million
5/8/2025	Q1 2025	TMDX TransMedics Group	$0.29	$0.70	+$0.41	$0.70	$123.39 million	$143.54 million
5/7/2025	Q1 2025	SLNO Soleno Therapeutics	-$1.14	-$0.95	+$0.19	-$0.95	N/A	N/A
5/5/2025	Q1 2025	INSP Inspire Medical Systems	-$0.23	$0.10	+$0.33	$0.10	$194.89 million	$201.32 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	0.01	4.73	3.74
INSP Inspire Medical Systems	N/A	9.01	7.44
SLNO Soleno Therapeutics	0.21	19.64	19.64
TMDX TransMedics Group	1.92	9.10	8.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
INSP Inspire Medical Systems	94.91%
SLNO Soleno Therapeutics	97.42%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
INSP Inspire Medical Systems	4.10%
SLNO Soleno Therapeutics	6.40%
TMDX TransMedics Group	7.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	440	47.83 million	46.78 million	Optionable
INSP Inspire Medical Systems	1,246	29.49 million	28.29 million	Optionable
SLNO Soleno Therapeutics	30	50.39 million	47.17 million	Optionable
TMDX TransMedics Group	210	33.82 million	31.46 million	Optionable

BLFS, SLNO, TMDX, and INSP Headlines

Recent News About These Companies

Teacher Retirement System of Texas Invests $330,000 in TransMedics Group, Inc. (NASDAQ:TMDX)

July 19 at 3:07 AM | marketbeat.com

Canaccord Genuity Group Issues Positive Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price

July 18 at 4:05 AM | americanbankingnews.com

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

July 16 at 4:19 PM | prnewswire.com

TransMedics Group (NASDAQ:TMDX) Given New $142.00 Price Target at Canaccord Genuity Group

July 15, 2025 | marketbeat.com

TransMedics: Q2 Analyst Estimates Will Fall Short

July 14, 2025 | seekingalpha.com

Emerald Advisers LLC Boosts Holdings in TransMedics Group, Inc. (NASDAQ:TMDX)

July 13, 2025 | marketbeat.com

Principal Financial Group Inc. Buys 5,480 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)

July 13, 2025 | marketbeat.com

What is William Blair's Estimate for TMDX Q1 Earnings?

July 13, 2025 | americanbankingnews.com

Emerald Mutual Fund Advisers Trust Grows Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX)

July 12, 2025 | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Moderate Buy" by Analysts

July 12, 2025 | americanbankingnews.com

TransMedics Group, Inc. (NASDAQ:TMDX) Receives Average Rating of "Moderate Buy" from Analysts

July 12, 2025 | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Stock Price Down 5.2% - What's Next?

July 11, 2025 | marketbeat.com

Brokers Issue Forecasts for TMDX Q1 Earnings

July 11, 2025 | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Stake Boosted by OneDigital Investment Advisors LLC

July 11, 2025 | marketbeat.com

New York State Teachers Retirement System Acquires 14,200 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)

July 10, 2025 | marketbeat.com

Vontobel Holding Ltd. Makes New $291,000 Investment in TransMedics Group, Inc. (NASDAQ:TMDX)

July 9, 2025 | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by Cambridge Investment Research Advisors Inc.

July 7, 2025 | marketbeat.com

TMDX - TransMedics Group Inc Executives - Morningstar

July 5, 2025 | morningstar.comM

TransMedics Group, Inc. (TMDX) Cash Flow - Yahoo Finance

July 4, 2025 | finance.yahoo.com

Is TransMedics Stock a Buy After Short-Seller Drama?

July 3, 2025 | fool.com

TMDX - TransMedics Group Inc Key Metrics - Morningstar

July 3, 2025 | morningstar.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLFS, SLNO, TMDX, and INSP Company Descriptions

BioLife Solutions NASDAQ:BLFS

$20.83 -0.59 (-2.75%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$20.82 0.00 (-0.02%)

As of 07/18/2025 04:09 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Inspire Medical Systems NYSE:INSP

$126.94 -1.03 (-0.80%)

Closing price 07/18/2025 03:59 PM Eastern

Extended Trading

$127.57 +0.63 (+0.49%)

As of 07/18/2025 06:16 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Soleno Therapeutics NASDAQ:SLNO

$87.20 -0.44 (-0.50%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$87.16 -0.05 (-0.05%)

As of 07/18/2025 04:32 PM Eastern

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

TransMedics Group NASDAQ:TMDX

$109.88 -2.64 (-2.35%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$110.54 +0.66 (+0.60%)

As of 07/18/2025 07:50 PM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time